Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia

Archives of Iranian Medicine

Volumn 12, Issue 1, 2009, Pages 55-59

  Rahimi, Firoozeh ^a   Alipour, Fateme ^a   Hashem, Hassan Ghazizadeh ^a   Hashemian, Mohammad Naser ^a   Mehrdad, Ramin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Mitomycin; Ocular surface; Squamous neoplasia

Indexed keywords

CORTICOSTEROID; LUBRICATING AGENT; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EXCISION; EYE CANCER; EYE DISEASE; EYE IRRITATION; EYE REDNESS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; OCULAR SURFACE SQUAMOUS NEOPLASIA; RETREATMENT; SCLERA DISEASE; SLIT LAMP; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; XERODERMA PIGMENTOSUM;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CONJUNCTIVAL NEOPLASMS; CORNEA; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; OPHTHALMIC SOLUTIONS; OPHTHALMOLOGIC SURGICAL PROCEDURES; PROSPECTIVE STUDIES; SCLERA; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59849124583     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Prabhasawat P, Tarinvorakup P, Tesavibul N, Uiprasertkul M, Kosrirukvongs P, Booranapong W, et al. Topical 0.002% mitomycin- C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea. 2005; 24: 443-448.
2. Akpek EK, Ertoy D, Kalayci D, Hasiripi H. Postoperative topical mitomycin-C in conjunctival squamous cell neoplasia. Cornea. 1999; 18: 59-62.
3. Kaines A, Davis G, Selva D, Leibovitch I, Dodd T, Malhotra R. Conjunctival squamous cell carcinoma with perineural invasion resulting in death. Ophthalmic Surg Lasers Imaging. 2005; 36: 249-251.
4. Frucht-Pery J, Rozenman Y, Pe'er J. Topical mitomycin-C for partially-excised conjunctival squamous cell carcinoma. Ophthalmology. 2002; 109: 548-552.
5. Frucht-Pery J, Sugar J, Baum J, Sutphin JE, Pe'er J, Savir H, et al. Mitomycin-C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology. 1997; 12: 2085-2093.
6. Wilson MW, Hungerford JL, George SM, Madreperla SA. Topical mitomycin-C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol. 1997; 124: 303-311.
7. Maskin SL. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol. 1994; 112: 1145-1146.
8. Kobayashi A, Yoshita T, Uchiyama K, Shirao Y, Kitagawa K, Fujisawa A, et al. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b. Jpn J Ophthalmol. 2002; 46: 215-217.
9. Vann RR, Karp CL. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology. 1999; 106: 91-97
10. Siganos CS, Kozobolis VP, Christodoulakis EV. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation. Cornea. 2002; 21: 12-16.
11. Barbazetto IA, Lee TC, Abramson DH. Treatment of conjunctival squamous cell carcinoma with photodynamic therapy. Am J Ophthalmol. 2004; 138: 183-189.
12. Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol. 1997; 115: 808-815.
13. Shields CL, Naseripour M, Shields JA. Topical mitomycin-C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol. 2002; 133: 601-606.
14. Sweetman SC. Martindale: The Complete Drug Reference. 34th ed. London: Pharmaceutical Press; 2005: 573-575.